Built by Claude Fable

Salesforce, Inc. — 6.15/10

BUY

NYSE: CRM | The #1 CRM franchise (~20-21% share) at a mature-industrial multiple. GAAP operating margin went 2.1% to 21.5% in five years and FCF 3.5x'd to $14.4B at a 34.7% margin, but organic growth has fallen to ~8.7% and the core applications bucket grows just 7% cc. Six straight EPS beats are substantially investment marks and an 11% share-count reduction, not demand. You pay 14.9x guided FY27 EPS and an 8.8% FCF yield for an unresolved agentic-AI question. Quality gate: ALL PASS.

Provisional score
Struck 2026-08-21, five days before the FY2027 Q2 print on 2026-08-26. Guidance of $3.25–3.27 non-GAAP EPS sits on consensus of $3.27 — effectively zero cushion — and the stock is ~21% above its 50-day average going in. Roughly 95% of the composite weight is contingent on that one event. Pre-committed triggers are at the foot of this page.

FY27Q1 Revenue

$11.1B

+13.3% YoY | ~8.7% organic

Non-GAAP Op Margin

34.8%

+250bps YoY | GAAP 21.1%

FY2026 FCF

$14.4B

34.7% margin | 3.5x since FY21

FY27E P/E

14.9x

8.8% FCF yield | 13.5x FY28E

Company overview

Salesforce, Inc. is the #1 customer relationship management franchise globally, holding roughly 20–21% of the CRM applications market — larger than the next several vendors combined. The front office is a genuine oligopoly alongside Microsoft Dynamics, Oracle and SAP. The company sells the system of record for customer data, priced per seat on multi-year subscriptions: ~95% of revenue is recurring, gross margin is 77%, and $67.9B of total contracted backlog ($33.6B current) sits ahead of the P&L, covering 73% of the FY27 revenue guide before the year begins.

Under co-founder Marc Benioff (CEO since 1999) and President/CFO/COO Robin Washington, Salesforce executed one of the largest margin transformations in software history: GAAP operating margin rose from 2.1% in FY21 to 21.5% in FY26 (+1,940bps) while free cash flow went from $4.09B to $14.40B, a 3.5x increase at a 34.7% margin. Revenue attrition held at roughly 8% throughout.

The tension is that growth was not restored alongside the margin. Organic revenue growth has been sub-10% for three consecutive years and is guided to decelerate to ~6% in Q2 FY27. The reported +13.3% in FY27Q1 included $444M of acquired Informatica revenue (~4.5pts). Management has committed to organic reacceleration in the second half of FY27 — the single falsifiable claim in the story, and the reason this score is provisional.

Chair & CEO	Marc Benioff (co-founder, 1999)	President, CFO & COO	Robin Washington (2025)
FY2026 Revenue	$41,525M (+9.6% YoY)	FY2026 FCF	$14,402M (34.7% margin)
CRM market share	~20-21% (#1 globally)	Recurring revenue	~95%
cRPO / Total RPO	$33.6B (+14%) / $67.9B (+11%)	Agentforce ARR (organic)	$1.2B (+205% YoY)
Net debt	$27.4B ($39.3B gross)	Goodwill	$59.3B (56% of assets)
Market cap / Employees	$172.2B / 83,334	Diluted shares	871M (-10.2% YoY)
FYE	January 31	Quality Gate	PASS (0 NOs)

Score breakdown

/ 10

Financial Trends Weight: 25%

One of the largest margin transformations in software history: GAAP operating margin 2.1% to 21.5% in five years (+1,940bps), FCF 3.5x to $14.4B at a 34.7% margin, at least ten consecutive quarters of margin expansion, churn flat at ~8%, diluted shares -10.2%. Held to 7 rather than 8-9 because earnings quality in the two biggest beats is poor -- $0.51 of FY27Q1's $3.88 is a strategic-investment mark Salesforce does not exclude, so operating EPS grew ~28% not 50% -- and organic growth has been sub-10% for three straight years.

/ 10

Thematic Exposure Weight: 35%

The heaviest weight and the crux of the score. Salesforce owns the customer system of record that agents must transact against, and is monetising it: $1.2B organic Agentforce ARR +205%, Agentic Work Units +111% Q/Q, tokens +152% Q/Q, premium AI SKU bookings +60%, and -- critically -- Sales and Service both still showing Y/Y seat growth with 7 of the top 10 deals adding new seats. The bears' headline datapoint (core Agentforce Apps +7% cc) blends Sales/Service with the legacy Marketing and Commerce drag, so it overstates the erosion case. A modest tailwind with an unresolved sign, not the coin flip a 5 implies.

/ 10

Management Quality Weight: 20%

Elite execution on the axes management controls -- +1,940bps of operating margin at a $40B revenue base, six straight EPS beats, ~99% of FY26 FCF returned, and the FY27 revenue guide raised rather than cut. Capped at 6 by a capital-allocation record with a real structural flaw: $59.3B of goodwill (56% of assets) built from serial M&A while organic growth halved, the same three acquired assets named as the drag for six consecutive quarters with no fix, a self-inflicted cash-flow walkback and margin-guide cut inside one quarter, and Chair+CEO plus CFO+COO authority concentrated in two people with no named successor.

/ 10

Investor Sentiment Weight: 5%

Scored contrarian: crowded scores low, washed-out scores high. Genuinely de-rated at 14.9x guided FY27 EPS and an 8.8% FCF yield, with price targets collapsing from a $286 yearly average to $260 quarterly to a single $222 in the last month as coverage thins. Not one of the 33 published FY27 models -- nor any of the 6 FY30 models -- assumes reacceleration. Far less crowded than the ADSK 4/10 anchor. Held to 7 because 76% of ratings remain bullish, leaving downgrade capacity, and the stock has run 21% off its 50-day average straight into a zero-cushion print.

/ 10

Concerns & Risks Weight: 15%

Solvency is not in question -- ~10x interest cover, net debt 1.8x FY27E FCF, $11.8B liquid, $67.9B of contracted backlog. But three hazards are real and near-dated: earnings quality now depends on a $7.77B strategic portfolio marked through the P&L where a 10% reversal is ~-$0.70/share; the $25B debt-funded ASR took gross debt $14.4B to $39.3B and permanently removes ~$1.4B/yr of FCF; and a zero-cushion print lands in five days with the 2H reacceleration promise untested against a decelerating ~6% Q2 organic guide.

Composite

Dimension	Score	Weight	Weighted
Financial Trends	7	25%	1.75
Thematic Exposure	6	35%	2.10
Management Quality	6	20%	1.20
Investor Sentiment	7	5%	0.35
Concerns & Risks	5	15%	0.75
Composite		100%	6.15

The first-pass analyst composite was 5.55. PM review revised Financial Trends 6→7 and Thematic Exposure 5→6 to reach 6.15. The full audit trail of what changed and why is on the Concerns & Risks page.

Summary thesis

A genuine oligopoly leader — #1 in CRM at ~20–21% share, ~95% recurring revenue, 77% gross margins, $67.9B of contracted backlog — that has already delivered one of software's great margin turnarounds (2.1% to 21.5% GAAP operating margin, FCF 3.5x to $14.4B) and now trades at a multiple that assumes none of it continues. At 14.9x guided FY27 non-GAAP EPS, 13.5x FY28 consensus and an 8.8% FCF yield, with literally no published model assuming reacceleration, you are not paying for the outcome you are underwriting.

The drag is that growth was never restored alongside the margin. Organic growth is ~8.7% falling to a guided ~6%, the reported acceleration was purchased with Informatica, and the six-quarter beat streak is substantially $558M of investment marks plus an 11% share-count reduction rather than demand — revenue surprises never exceeded ±1%. Management then spent the balance-sheet cushion on a $25B levered ASR that permanently removes ~$1.4B/year of free cash flow.

The call is BUY — half-size starter now, second half after the print. The asymmetry earns it: roughly 15–20% of de-rating room against 40%+ if second-half organic reaccelerates and the market re-rates a Rule-of-50 story (see the bull case). But the calendar demands respect — an in-line operating quarter converts to a printed miss on one adverse investment mark.

Quality gate: PASS (0 NOs). Oligopoly YES, positiveGrowingFcf YES, managementTrackRecord YES.

Pre-committed triggers for the 2026-08-26 print

Outcome	Action
Non-GAAP EPS at or above $3.27 with strategic-investment marks at or below $100M	Earnings quality resolved; Financial Trends holds 7
Q2 organic at or above 6% and cRPO at or above 13% cc and 2H language reaffirmed	Thematic to 7; composite ~6.5; add the second half of the position
Q2 organic below 6%, or cRPO below 13% cc, or any softening of the 2H commitment	Thematic to 5, Management to 5; composite ~5.5; exit
Attrition re-quantified above 8%, or Sales/Service seat growth turns negative	Thematic to 4 regardless of the EPS line; exit

Financials from the Financial Modeling Prep API (24 quarters, 8 years). Operating metrics, guidance, backlog and segment detail from the Salesforce IR quarterly results release. Management commentary verified verbatim against earnings call transcripts FY2025Q4-FY2027Q1. Daloopa was not used on this build. Analysis date 2026-08-21, price $210.30.